FDA's Baby Bottle Check: Time to Rethink Formula Ingredients?
Published Date: 5/14/2025
Notice
Summary
The FDA wants your input to review and possibly update the nutrients in baby formula sold in the U.S. This affects formula makers, parents, and babies by aiming to keep formulas healthy and safe. The FDA is gathering info now to decide if changes are needed, so stay tuned for updates that could impact what’s in your baby’s bottle and when.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
FDA Reviewing Infant Formula Nutrients
If you are a parent or guardian of an infant, the FDA is asking for information to review and possibly update the nutrient requirements for infant formula sold in the United States. The review aims to help ensure formulas are nutritionally adequate and safe and could lead to future changes in what is required in baby formula.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-19704, Robotically-Assisted Surgical Devices-Premarket Submissions; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA just dropped a draft guide for companies making robot-assisted surgical devices, showing how to get their products approved before selling. If you’re in the biz, now’s the time to check it out and send your feedback by November 24, 2026. This guide aims to make the approval process clearer and smoother, potentially saving time and money down the road.
2026-19655, Jeffrey Thies: Final Debarment Order
Jeffrey Thies is banned for 10 years from importing any drugs into the U.S. because he was convicted of trafficking fake drugs. He didn’t respond to the FDA’s notice, so the ban started on September 25, 2026. He can apply to end the ban anytime, but until then, no drug imports for him!
Previous / Next Documents
Previous: 2025-08418, Agency Information Collection Request. 30-Day Public Comment Request
The Department of Health and Human Services wants your thoughts on a new info collection plan. If you’re part of a group that shares data with them, this could affect you. They’re asking for comments within 30 days—no big costs, just a chance to help shape the process!
Next: 2025-08420, Agency Information Collection Request. 30-Day Public Comment Request
The Department of Health and Human Services wants your thoughts on a new info collection plan. If you or your group fill out government forms, this could affect you. They’re asking for comments within 30 days—no extra costs yet, just your feedback to keep things smooth and simple!